Passage Bio Inc.
PASG | NASDAQ
$4.81
-$0.02 (-0.41%)
Sep 22, 2026, 12:25 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 728K | n/a | 3.72M | n/a | n/a | n/a |
Gross Profit | -728K | n/a | -3.72M | n/a | n/a | n/a |
Operating Income | -43.15M | -70.4M | -100.14M | -138.39M | -185.73M | -112.9M |
Interest Income | 2.3M | 4.3M | 5.6M | 2.27M | 343K | 670K |
Pretax Income | -45.52M | -64.77M | -102.06M | -136.13M | -185.39M | -112.23M |
Net Income | -45.52M | -64.77M | -102.06M | -136.13M | -185.39M | -112.23M |
Selling & General & Admin | 19.88M | 24.99M | 41.58M | 49.34M | 60.06M | 30.11M |
Research & Development | 23.28M | 40.18M | 59.56M | 86.05M | 117.67M | 82.79M |
Other Expenses | -728K | 5.23M | -4.72M | 3M | 8M | n/a |
Operating Expenses | 42.42M | 70.4M | 96.42M | 138.39M | 185.73M | 112.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 43.15M | 70.4M | 100.14M | 138.39M | 185.73M | 112.9M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.17M | 3.02M | 2.74M | 2.72M | 2.67M | 2.28M |
Shares Outstanding (Diluted) | 3.17M | 3.02M | 2.74M | 2.72M | 2.67M | 2.28M |
EPS (Basic) | -14.35 | -21.44 | -37.29 | -50 | -69.51 | -57.80 |
EPS (Diluted) | -14.35 | -21.44 | -37.29 | -50 | -69.51 | -57.80 |
EBITDA | -44.79M | -62.09M | -98.34M | -131.72M | -176.19M | -111.1M |
EBIT | -45.52M | -65.17M | -102.06M | -135.39M | -177.73M | -111.9M |
Depreciation & Amortization | 728K | 3.08M | 3.72M | 3.68M | 1.54M | 800K |
Add to Watchlist
Select watchlists to add or remove PASG